4 signs you should sell Commonwealth Bank of Australia

Commonwealth Bank of Australia (ASX:CBA) has had an excellent run but that mightn't continue for much longer.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Commonwealth Bank of Australia (ASX: CBA) shares have been an incredible investment for investors in recent years. With low interest rates and falling bad debts, the bank has managed to produce record annual profits, while at the same time increasing its already lucrative dividend distributions.

The problem is, many investors are holding onto that strong history and assuming the stock can continue to deliver market-crushing performance over the coming years – a scenario that is looking increasingly unlikely. Here are four reasons why you should consider selling your Commonwealth Bank shares.

1.  Valuation. At $85.23, the stock is trading within 2% of its all-time high which was recorded late last month. At that price, it's trading on a price-book ratio of 2.8 times as well as a price-earnings ratio of 16.1 times last financial year's earnings, making it one of the most expensive bank stocks in the world.

2.  Growth. The bank's profit growth could come under significant pressure in the coming 12 months with bad debt charges tipped to rise and competition for new customers expected to continue heating up. Earnings growth may be in the mid-single digits which would hardly justify its premium valuation.

3.  Dividends. The bank's incredible fully franked yield has played a key role in attracting investors over the years, but it may struggle to grow or even maintain its current dividend if new regulations are put in place. The big four banks will likely be required to hold more capital in reserve which could see that dividend growth slow down, which would no doubt see some investors head for the exits.

4.  Better opportunities. Here at The Motley Fool, our ideal holding time is 'forever'. However, one of the reasons Foolish investors would consider selling is if there are stronger alternatives which could grow our wealth at a faster clip. Regardless of whether Commonwealth Bank rises another few percentage points, the returns are highly unlikely to match those of some of the market's other promising stocks.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »